ProbiSearch acquired by CZ Veterinaria

Vigo-based bio-technological company Biofabri (part of the CZ Veterinaria-Biofabri Group) completed the acquisition of Madrid-based Probisearch, a technological company part of the Complutense University, created to identify and select bacterial strains for the manufacturing of probiotics. The acquisition will help the company move forward with its growth strategy, which started a few years ago, and will consolidate its positioning in the bio-technology industry. “This shows our commitment to a future business line in the development and manufacturing of pharmaceutical-grade probiotics.”
Probisearch, previously owned by the Complutense University and a group of UCM researchers, is also working on the development of clinical trials of the above strains for a range of human and veterinarian applications. In 2011 Probisearch was the recipient of the IV Complutense Award for Best Idea and New Technology-Based Company and Scientific Communication, granted by the Bureau of Transfer Results of Research (OTRI) – UCM in the Business Plan category. Biofabri will retain the staff of the newly-acquired company, according to sources in the Galician Group.
The Vigo-based biotech Group CZ Veterinaria-Biofabri has designed an intensive 10-year business plan. This will see the group launching 12 new vaccines (8 vaccines for animals and 4 vaccines for humans), multiplying by three the production capacity of its manufacturing plants in Torneiros (Porriño) and entering the nutritional supplement (probiotics) market in late 2017, as reported last November by newspaper Faro de Vigo. The group will invest a total of EUR10 million in the next two years to increase and optimize its production lines.
The company already invested EUR1 million to reconfigure a manufacturing facility for the production of the first of the new range of probiotics (functional foods). The new range will be available at the end of the year.

Published in Spanish newspaper Faro de Vigo, 17 January 2017.